Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Ritonavir and lopinavir may stop the growth of gliomas by blocking some of the
enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase
II trial is studying how well giving ritonavir together with lopinavir works in treating
patients with progressive or recurrent high-grade glioma.